In breast cancer cells, hsa-miR-195 induces apoptosis by targeting genes such as Bcl-2 and FASN; however, aberrant activation of MYC can antagonize the pro-apoptotic effect of miR-195 by upregulating anti-apoptotic proteins like Bcl-xL. This evidence concerns the gene BCL2L1 and breast carcinoma.